Diagnostic and Interventional Cardiology

Signify Research industry analyst drives home the importance of being well informed of existing technology and prepare the necessary due diligence to ensure their solution is not infringing on existing technological patents

Feature | Wearables | By Kelly Patrick

The use of wearable technology in healthcare is continuing to evolve with high interest, driving technology innovation ...

May 22, 2023

Results from global trial of the POLARx Cryoablation System* meet safety and effectiveness endpoints

News | Left Atrial Appendage (LAA) Occluders

Real-world outcomes from the EU-PORIA registry of the FARAPULSE Pulsed Field Ablation (PFA) System

May 22, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...

May 22, 2023

Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD) were presented during the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions, held May 18-20 in Phoenix, AZ. Results found marijuana users are at a significantly increased risk of developing PAD, compared to the general population.

News | SCAI

Marijuana Users Three Times More Likely to Develop Peripheral Artery Disease

May 19, 2023 — Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD ...

May 19, 2023

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

The platform is designed to expand the information available to clinicians prescribing the Epi+Gen CHD and PrecisionCHD laboratory developed tests (LDTs)

News | Artificial Intelligence

Cardio Diagnostics Holdings, Inc’s Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management

May 19, 2023 — Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine ...

May 19, 2023

Figure 1. Results from the PROTECT II RCT, PROTECT III and RESTORE-EF Pooled Data Analysis

News | Intra-Aortic Balloon Pumps (IABP)

Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP during HRPCI

May 19, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing that ...

May 19, 2023

Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves

News | Structural Heart

New Late-breaking Data Reinforce the Benefits of Abbott's TriClip Device for People with Tricuspid Valve Disease

May 19, 2023 — Abbott announced late-breaking data that add to the body of clinical evidence supporting the benefits of ...

May 19, 2023

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

$Assert-IQ\ ICM is the world’s longest lasting Bluetooth - enabled insertable cardiac monitor$

News | Implantable Cardiac Monitor (ICM)

Abbott Receives FDA Clearance for Assert-IQ Insertable Cardiac Monitor

May 18, 2023 — Abbott announced its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug ...

May 18, 2023

The first of Vektor Medical's new studies, being presented at HRS 2023, showcases vMap’s utility in unstable ventricular tachycardia (VT) ablation. (Graphic: Business Wire)

News | Atrial Fibrillation

Vektor Medical Releases Compelling Results for vMap Utility

May 18, 2023 — Vektor Medical, pioneers of technology to accurately map arrhythmias using only 12-lead ECG data ...

May 18, 2023

54-year-old patient with COVID-19 who underwent full angiographic reperfusion (extended thrombolysis in cerebral ischemia score = 3) after acute ischemic stroke. Top: Automated readout summary of CT perfusion data at presentation shows large mismatch volume (54 mL). Bottom: Follow-up MR image shows progression in infarction growth, with final infarction volume of approximately 72 cm3 (600% increase from CT perfusion imaging estimate of 9 mL shown in A).

News | Coronavirus (COVID-19)

Infarction Growth, Penumbral Consumption After Reperfusion in COVID Vaccine-Naïve Patients

May 18, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), SARS ...

May 18, 2023

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

News | Atrial Fibrillation

Jasmina Brooks Named President of Biosense Webster

May 17, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmiatreatment and part of Johnson & Johnson ...

May 17, 2023

R-One+ is a robotic solution that allows the interventional cardiologist to perform coronary angioplasties by controlling the devices using an integrated control command unit located in the cathlab or in the control room

News | Robotic Systems

Robocath Launches New Robotic Platform R-One+

May 17, 2023 — Robocath, a company that designs, develops and commercializes smart robotic solutions for the treatment ...

May 17, 2023

Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement (TAVR) with balloon-expandable valves.

News | Structural Heart

Data from Benchmark Registry Demonstrate Improved TAVR Efficiency with Preserved Patient Safety

May 17, 2023 — Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the ...

May 17, 2023

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Late-breaking clinical data presented at EuroPCR 2023 in Paris demonstrated Elixir Medical’s DynamX Bioadaptor restores vessel motion and function with better effectiveness at 12 months compared to a leading drug-eluting stent (DES).

News | EuroPCR

EuroPCR Late-Breaking Clinical Trial Data Finds Effectiveness of Elixir Medical’s DynamX Bioadaptor for PCI Treatment

May 17, 2023 — Elixir Medical has reported that important data were presented at a late-breaking clinical session during ...

May 17, 2023

Videos | Information Technology

VIDEO: Using Maturity Models to Measure Digital Health

HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS ...

May 17, 2023

Heart Rhythm 2023, the society's 44th annual meeting, taking place May 19-21, in New Orleans

Feature | HRS | By Melinda Taschetta-Millane

HRS23 Announces Late-breaking Clinical Trials and Science Sessions

The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions, including late-breaking clinical ...

May 17, 2023